Clinical Trial

International Post Market Surveillance Study of Intracranial Aneurysms Treated With an Endovascular Approach

Study acronym: IMPACT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
IMPACT is an observational, post market study designed to provide an ongoing safety and performance evaluation of Stryker Neurovascular devices used for the treatment of intracranial aneurysms with an endovascular approach.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2020-09-25; most recent amendment 2025-08-05.
Status change: Recruiting → Active, Not Recruiting 2023-10-23
Status change: Not Yet Recruiting → Recruiting 2021-03-10
Trial Details
NCT Number NCT04572230
Lead Sponsor Stryker Neurovascular
Conditions Intracranial Aneurysm
Enrollment 405 participants
Start Date 2020-12-21
Primary Completion 2024-10-24 (estimated)
Study Completion 2025-08 (estimated)
Updated on ClinicalTrials.gov 2025-08-07